Background
Methods
Study location and participants
Study procedures
Clinical assessment
Echocardiography measurements
Electrocardiography measurements
Data analysis
Results
Recruitment
Baseline data
Category | Feature present at admission | Group 1 Bolus + rehydration | Group 2 Rehydration only |
P value | ||
---|---|---|---|---|---|---|
Total number | N | 11 | n | 9 | N/A | |
Malnutrition type | Oedematous (Kwashiorkor) | 10 | (90.9%) | 5 | (55.6%) | 0.08 |
Sex | Male (%) | 5 | (45.5%) | 7 | (77.8%) | 0.15 |
Age | Median age (months) | 21 | (12–43) | 24 | (9–49) | 0.65 |
Anthropometry | Median weight (kg) | 6.1 | (5–10) | 6 | (4–10) | 0.91 |
Median MUAC (cm) | 11.5 | (8.5–12.4) | 10.2 | (7–12.3) | 0.20 | |
Clinical | Fever (axillary temperature >37.5 °C) | 0 | (0%) | 0 | (0%) | N/A |
Hypothermia (axillary temperature <35.0 °C) | 5 | (45.5%) | 2 | (22.2%) | 0.19 | |
Tachypnoea (respiratory rate >40 breaths/minute) | 4 | (36.4%) | 6 | (66.7%) | 0.52 | |
Chest indrawing | 10 | (100%) | 9 | (100%) | N/A | |
Deep breathing (respiratory distress) | 9 | (90%) | 4 | (44.4%) | 0.04 | |
Hypoxia (percutaneous oxygen saturation <90%) | 5 | (45.5%) | 5 | (62.5%) | 0.45 | |
Tachycardiaa
| 1 | (9.1%) | 4 | (44.4%) | 0.09 | |
Bradycardia (heart rate <80 beats/minute) | 1 | (9.1%) | 1 | (11.1%) | 0.32 | |
Prolonged capillary refill time (>3 seconds) | 5 | (45.5%) | 4 | (44.4%) | 0.59 | |
Weak pulse volume | 7 | (63.6%) | 6 | (66.7%) | 0.89 | |
Temperature gradient | 11 | (100%) | 9 | (100%) | N/A | |
Decreased skin turgor (dehydration) | 6 | (54.5%) | 7 | (77.8%) | 0.82 | |
Prostration or coma | 9 | (81.8%) | 4 | (44.4%) | 0.18 | |
Shock | WHO shock definitionb
| 4 | (36.4%) | 3 | (33.3%) | 0.58 |
Heart failure definition (see Table 2: definitions of heart failure) | Congestive cardiac failure (CCF) | 1 | (9.1%) | 2 | (22.2%) | 0.70 |
Myocardial dysfunction (MD) | 2 | (18.2%) | 1 | (11.1%) | 0.35 | |
Elevated brain natriuretic protein (BNP) | 6 | (54.5%) | 2 | (22.2%) | 0.39 | |
All three (CCF, MD plus BNP) | 1 | (9.1%) | 1 | (11.1%) | 0.67 | |
Laboratory | Severe anaemia (haemoglobin <5 g/dL) | 2 | (22.2%) | 0 | (0%) | 0.27 |
Leukocytosis (white blood cell count >12.5 × 1012/L) | 6 | (66.7%) | 3 | (37.5%) | 0.56 | |
Thrombocytopenia (platelet count <160 × 1012/L) | 5 | (55.6%) | 6 | (75%) | 0.28 | |
Severe hyponatremia (sodium <125 mmol/L) | 4 | (36.4%) | 5 | (62.5%) | 0.41 | |
Severe hypokalemia (potassium <2.5 mmol/L) | 5 | (50%) | 3 | (37.5%) | 0.37 | |
Hypoglycaemia (blood glucose <3 mmol/L) | 1 | (12.5%) | 5 | (62.5%) | 0.02 | |
Hypercreatinaemia (creatinine >80 μmol/L) | 4 | (40%) | 3 | (37.5%) | 0.82 | |
Hyperlacataemia (lactate >3 mmol/L) | 3 | (33.3%) | 3 | (33.3%) | N/A | |
Microbiology/malaria | Malaria parasitaemia (blood film) | 5 | (55.6%) | 3 | (42.9%) | 0.63 |
a) Clinical: probable congestive cardiac failure (CCF) scored on a scale ranging from 0 to 5 based on the following signs listed in the WHO guidelines [1]: (1) tachycardia (heart rate >160/minute in a child <12 months of age or >120/minute in a child aged 12 months to 5 years); (2) tachypnoea; (3) gallop heart rhythm; (4) tender hepatomegaly and (5) raised jugular venous pressure seen as distended neck veins. We used a score ≥3 as the cut-off for probable CCF. |
Interventions
Clinical features over time
Patients | Cardiac haemodynamics summary | Fluid resuscitation summary | |||||
---|---|---|---|---|---|---|---|
% ∆SVI | % ∆EDVI | % ∆SVRI | % ∆IVCCI | % ∆FS | Input (ml/kg/h) | Output (ml/kg/h) | |
Group 1 | |||||||
301 | -17 | -2 | -29 | -13 | -19 | 2.8 | 4.6 |
401a
| 16 | -24 | 10 | 66 | 7.4 | 1.5 | |
402 | -3 | -14 | 20 | 166 | 16 | 3.5 | 0.7 |
403 | 15 | -1 | -11 | 118 | 22 | 3.4 | 5.1 |
404 | -1 | 0 | 19 | 29 | -2 | 3.4 | 6.8 |
405 | 33 | 31 | -17 | 17 | 2 | 2.6 | 7.4 |
406 | -48 | -40 | 56 | -16 | -18 | 6.8 | 0.2 |
407 | 57 | 5 | -25 | 38 | 60 | 5.0 | 0.3 |
408 | 46 | 34 | 4 | -20 | 13 | 4.2 | 1.5 |
409 | 0 | -2 | -23 | 28 | 1 | 3.1 | 11.9 |
410 | -4 | 11 | 1 | -16 | -19 | 4.1 | 4.5 |
Group 2 | |||||||
411 | 30 | -18 | -10 | -32 | 77 | 4.3 | 3.3 |
412 | 5 | -10 | -46 | -34 | 19 | 8.4 | 1.9 |
413 | 27 | 17 | -15 | 25 | 12 | 2.9 | 0.6 |
414 | 34 | 42 | 7 | 0 | -6 | 2.0 | 6.0 |
415 | 3 | 6 | -2 | -28 | -4 | 2.8 | 3.2 |
416b
| - | - | - | - | - | 10.0 | 16.7 |
417b
| - | - | - | - | - | 10.0 | 0 |
418 | 25 | 21 | -18 | -66 | 5 | 4.0 | 3.9 |
419 | 30 | 20 | -18 | 29 | 6 | 1.4 | 8.5 |
Cardiac function before and after fluid administration
Parameter | Bolus + rehydration group (group 1) | Rehydration-only group (group 2) |
P value* | ||||
---|---|---|---|---|---|---|---|
Pre fluid Median, (IQR) | Post fluid Median, (IQR) | 24 h Median, (IQR) | Pre fluid Median, (IQR) | Post fluid Median, (IQR) | 24 h Median, (IQR) | ||
FS (%) | 28 (23, 31) | 30 (24, 32) | 29 (28, 31) | 31 (23, 33) | 31 (27, 35) | 28 (25, 29) | 0.89 |
IVCCI (%) | 30 (23, 46) | 38 (37, 39) | 34 (23, 39) | 38 (28, 44) | 28 (24, 35) | 23 (22, 26) | 0.97 |
SVI (ml/min/m2) | 30 (23, 45) | 34 (27, 43) | 33 (26, 37) | 30 (24, 32) | 32 (31, 41) | 38 (32, 39) | 0.81 |
CI (L/min/m2) | 6.6 (4.0, 8.3) | 6.3 (4.5, 7.5) | 5.0 (4.6, 5.8) | 6.9 (5.0, 8.5) | 6.9 (4.9, 7.6) | 6.2 (5.7, 7.0) | 0.90 |
EDVI (ml/min/m2) | 60 (48, 77) | 62 (52, 76) | 58 (44, 64) | 50 (48, 59) | 58 (51, 60) | 74 (58, 76) | 0.75 |
SVRI (ds/cm5/m2) | 1349 (1039, 1797) | 1275 (1189, 1610) | 1422 (1294, 1556) | 1265 (1155, 1969) | 1105 (1071, 1655) | 2102 (1883, 2113) | 0.77 |
Tei index | 0.28 (0.15, 0.40) | 0.38 (0.10, 0.44) | 0.27 (0.16, 0.32) | 0.24 (0.17, 0.25) | 0.15 (0.11, 0.32) | 0.27 (0.25, 0.34) | 0.73 |
Heart rate | 106 (99, 113) | 108 (102, 116) | 111 (102, 129) | 144 (109, 160) | 130 (103, 170) | 105 (103, 111) | 0.19 |
GRS (%) | 27 (12, 37) | 24 (14, 36) | 32 (13, 39) | 21 (18, 29) | 46 (31, 47) | 32 (20, 34) | 0.15 |
GCS (%) | -18 (-22, -15) | -19 (-25, -18) | -17 (-19, -14) | -19 (-25, -14) | -21 (-26, -18) | -21 (-21, -20) | 0.81 |
GLS (%) | -23 (-24, -18) | -21 (-25, -15) | -22 (-25, -18) | -22 (-23, -19) | -20 (-23, -19) | -19 (-19, -17) | 0.69 |
ECG parameter | Group 1 Median (IQR) | Group 2 Median (IQR) |
P value* | ||
---|---|---|---|---|---|
Admission (n =11) | 24 h (n = 8) | Admission (n = 9) | 24 h (n = 5) | ||
P wave duration | 78 (74, 145) | 85 (73, 107) | 88 (70, 160) | 92 (92, 128) | 0.53 |
PR interval | 130 (111, 178) | 127 (112, 215) | 148 (102, 186) | 130 (130, 182) | 0.96 |
QRS duration | 76 (66, 80) | 75 (63, 78) | 66 (64, 72) | 70 (62, 74) | 0.42 |
RR interval | 546 (490, 579) | 562 (513, 609) | 460 (414, 540) | 594 (540, 600) | 0.96 |
PP interval | 545 (490, 575) | 565 (511, 610) | 455 (415, 540) | 590 (540, 600) | 0.93 |
QT interval | 318 (294, 378) | 337 (293, 351) | 344 (276, 360) | 370 (276, 384) | 0.59 |
QTc | 461 (423, 509) | 459 (437, 471) | 473 (414, 509) | 472 (422, 516) | 0.64 |